Skip to main content

Omicron Variant Could Be Potent for Pharma Stocks, ETFs

According to reports out Wednesday, the first U.S case of the Omicron variant of the coronavirus was discovered in California. More research is needed on the Omicron strain, but there’s already ample chatter that it could require booster shots or perhaps even its own vaccine, signaling a...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.